Based on previous reports linking IFNL3/IFNL4 genotypes and fibrosis risk (16, 17, 34) and our current results on association with cirrhosis risk in HCV patients, we explored molecular mechanisms that could explain these associations. The gene discussed is IFNL3; the disease is fibrosis.